Skip to main content
Fig. 6 | Thyroid Research

Fig. 6

From: The value of thyroperoxidase as a prognostic factor for differentiated thyroid cancer -- a long-term follow-up study

Fig. 6

a Overall survival according to TPO level: overall survival decreases with TPO expression. b Overall survival according to TNM stage: Overall survival decreased with TNM stage, with a 20-year survival of 90 %, 83 % and 52 % in stages II, III and IV, respectively. c Disease-free survival according to TPO expression: d Disease-free survival according to TNM stage: The figure shows how disease-free survival (DFS) decreased with TNM stages, with 95 % in stage I, 47 % in stage II, 29 % in stage III, and 0 % in stage IV

Back to article page